Mechanisms of Cerebrovascular Control

NCT02936687 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome X

Interventions

DRUG: NOS Inhibition
DRUG: ET-1 Inhibition
DRUG: NOS Inhibition Placebo
DEVICE: 3 Tesla MRI
DEVICE: Intravenous Catheter
OTHER: Oral Glucose Tolerance Test
DRUG: ET-1 Inhibition Placebo

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]
[object Object]